Mineralocorticoid receptor antagonists: Efficacy and safety in chronic kidney disease.

Diabetes Obes Metab · 2026 · PMC13071264 · PMID 41804208

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

74 Furthermore, in FIGARO‐DKD, a nominal 13% reduction in the risk of the secondary kidney outcome (primary outcome of FIDELIO‐DKD) was observed for finerenone versus placebo, but this did not reach statistical significance (95% CI: 0.75–1.01). 74 FIDELITY was a prespecified pooled analysis from the complementary FIDELIO‐DKD and FIGARO‐DKD trials.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.